Laura K. Fishwick
Hatch-Waxman, PTAB, and Life Sciences Patent Strategy
Laura has significant experience in Abbreviated New Drug Application (ANDA) litigation, including matters involving highly complex chemical and life sciences technologies. Her patent litigation experience spans pre-suit investigations through appeal, including claim construction briefing and Markman hearings, summary judgment briefing and hearings, motions practice, fact and expert discovery, trials, and appeals. She also supports patent due diligences involving biotechnology and pharmaceutical patent portfolios.
Laura's educational background in hard science informs her detail-oriented approach to complex patent disputes involving pharmaceutical and biotechnology innovations. She is known for developing a command of the technical record, providing responsive client service, and focusing on strategies that advance her clients' business and litigation objectives.
Laura began her legal career practicing patent litigation at the intellectual property firm Fitzpatrick, Cella, Harper & Scinto, which is now part of Venable.
Related Practices
Related Industries
Experience
Representative Matters
- Represented Novartis in Novartis v. Breckenridge, West-Ward and Par (Zortress® (everolimus) for kidney and liver transplants) (D. Del., Fed. Cir., PTAB-IPR)
- Represented Novartis in Novartis v. West-Ward (Afinitor® (everolimus) for renal cell carcinoma and pancreatic neuroendocrine tumors) (D. Del., Fed. Cir., PTAB-IPR)
- Represented Novartis in Novartis v. Par (Afinitor® (everolimus) for breast cancer) (D. Del.)
- Represented Novartis in Novartis v. Breckenridge (Afinitor® (everolimus) for renal cell carcinoma, renal angiomyolipoma, and tuberous sclerosis complex with subependymal giant cell astrocytoma) (D. Del., PTAB-IPR)
- Represented Novartis in Novartis v. Mylan (Afinitor® Disperz (everolimus) for tuberous sclerosis complex with subependymal giant cell astrocytoma) (D. Del.)
Representative Clients
- Novartis
Insights
Credentials
Education
- J.D. Harvard Law School 2013
- Digest submissions editor, Harvard Journal of Law and Technology
- B.S. Biochemistry and Molecular Biology summa cum laude University of Florida 2010
Bar Admissions
- New York
- U.S. Patent and Trademark Office
Court Admissions
- U.S. District Court for the Southern District of New York
- U.S. Court of Appeals for the Federal Circuit
Recognition
- The Best Lawyers in America, Ones to Watch, 2021 – 2022, 2024 – 2025